Orpyx’s CEO and Co-Founder awarded Governor General’s Innovation Award

Dr. Breanne Everett selected as one of six inaugural winners

Calgary, AB, Canada, April 28, 2016 - Orpyx Medical Technologies Inc. (“Orpyx”) is proud to announce its CEO and Co-Founder, Dr. Breanne Everett was named one of the six national winners of the inaugural Governor General’s Innovation Award in Canada.

The goal of the Governor General’s Innovation Award is to inspire Canadians to embrace innovation and to emulate innovative, entrepreneurial risk-takers who have developed new or groundbreaking ways of creating value and a meaningful impact on our quality of life.

“I am thrilled and honoured to receive the Governor General’s Innovation Award.” said Dr. Breanne Everett, CEO and Co-Founder, Orpyx. “Recognition like this is important in nurturing Canada’s innovation economy and I hope my efforts, and those of my team, can inspire others to do the same.”

The Governor General’s Innovation Awards recognize and celebrate outstanding Canadian individuals, teams, and organizations — trailblazers and creators whose innovations are exceptional and inspiring to the future of the next generation.

About the Governor General’s Innovation Award
The Governor General’s Innovation Awards is to inspire Canadians to embrace innovation and to emulate innovative, entrepreneurial risk-takers who have developed new or better ways of creating value and who are having a meaningful impact on our quality of life. As innovation and an entrepreneurial spirit are fundamentally important to all Canadians and can have a transformative, positive impact—regardless of whether it is in the private, public or not-for-profit realms—the awards encompass all sectors of Canadian society.

Each year, up to six award winners will be identified through a two-stage, merit-based selection process. This process is managed by the Canada Foundation for Innovation. The program operates on an annual cycle, with an awards ceremony held each spring. The Governor General’s Innovation Awards Advisory Committee, made up of highly accomplished Canadians from all sectors, provides oversight and strategic direction for the program. The Office of the Secretary to the Governor General oversees the execution of all aspects of the program.

To learn more about the Governor General’s Innovation Award and this year’s winners, please visit: 

About Orpyx Medical Technologies Inc.
Orpyx Medical Technologies Inc. (“Orpyx”) is a wearable pressure sensor technology company focused on medical applications. Orpyx’s primary intention is to address the world’s growing epidemic of diabetes and its associated complications, most notably, peripheral neuropathy, which leads to lack of circulation, numbness, or loss of protective sensation, in the feet. This problem leads to the development of foot ulcers which can ultimately lead to amputation and death infection and ulcers in the feet, also known as peripheral neuropathy. Additionally, this problem affects upwards of 60% of diabetics over the course of their disease and costs the North American health care system over $16.4 billion annually.

For more information, please contact:
Chan Mean
Marketing Manager, Orpyx Medical Technologies Inc.
chan.mean@orpyx.com
+1 403 460 0216 ext. 501




Chan Mean
Chan Mean

Author